Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
dc.contributor.buuauthor | Aydın, Mehmet Fethullah | |
dc.contributor.buuauthor | Yıldız, Abdülmecit | |
dc.contributor.buuauthor | Oruç, Ayşegül | |
dc.contributor.buuauthor | Sezen, Mehmet | |
dc.contributor.buuauthor | Dilek, Kamil | |
dc.contributor.buuauthor | Güllülü, Mustafa | |
dc.contributor.buuauthor | Yavuz, Mahmut | |
dc.contributor.buuauthor | Ersoy, Alparslan | |
dc.contributor.orcid | 0000-0002-5665-7402 | tr_TR |
dc.contributor.orcid | 0000-0002-0342-9692 | tr_TR |
dc.contributor.researcherid | JMQ-0549-2023 | |
dc.contributor.researcherid | AAJ-8220-2020 | |
dc.contributor.researcherid | AAH-4002-2021 | |
dc.contributor.researcherid | HIG-9032-2022 | |
dc.contributor.researcherid | EUF-5229-2022 | |
dc.contributor.researcherid | JGS-9425-2023 | |
dc.contributor.researcherid | EHM-7377-2022 | |
dc.contributor.researcherid | CPX-5894-2022 | |
dc.contributor.scopusid | 57197303645 | tr_TR |
dc.contributor.scopusid | 56256977500 | tr_TR |
dc.contributor.scopusid | 55133912100 | tr_TR |
dc.contributor.scopusid | 57225215002 | tr_TR |
dc.contributor.scopusid | 56005080200 | tr_TR |
dc.contributor.scopusid | 6602684544 | tr_TR |
dc.contributor.scopusid | 7006244754 | tr_TR |
dc.contributor.scopusid | 35612977100 | tr_TR |
dc.date.accessioned | 2024-01-22T10:55:46Z | |
dc.date.available | 2024-01-22T10:55:46Z | |
dc.date.issued | 2021-08 | |
dc.identifier.citation | Aydın, M. F. vd. (2021). "Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination". Kidney International, 100(2), 464-465. | en_US |
dc.identifier.doi | https://doi.org/10.1016/j.kint.2021.05.001 | |
dc.identifier.endpage | 465 | tr_TR |
dc.identifier.issn | 0085-2538 | |
dc.identifier.issn | 1523-1755 | |
dc.identifier.issue | 2 | tr_TR |
dc.identifier.pubmed | 33992674 | tr_TR |
dc.identifier.scopus | 2-s2.0-85109468464 | tr_TR |
dc.identifier.startpage | 464 | tr_TR |
dc.identifier.uri | https://www.sciencedirect.com/science/article/abs/pii/S0085253821004944 | |
dc.identifier.uri | https://hdl.handle.net/11452/39218 | |
dc.identifier.volume | 100 | tr_TR |
dc.identifier.wos | 000686900600029 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.journal | Kidney International | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Membranous glomerulonephritis | en_US |
dc.subject.emtree | Recurrent disease | en_US |
dc.subject.emtree | Vaccination | en_US |
dc.subject.mesh | COVID-19 | en_US |
dc.subject.mesh | Glomerulonephritis, membranous | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Recurrence | en_US |
dc.subject.mesh | SARS-CoV-2 | en_US |
dc.subject.mesh | Vaccination | en_US |
dc.subject.wos | Urology & Nephrology | en_US |
dc.title | Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination | en_US |
dc.type | Article | en_US |
dc.wos.quartile | Q1 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: